Hexapeptide-11

What is Hexapeptide-11?

Hexapeptide-11 is a synthetic hexapeptide with the sequence Phe-Val-Ala-Pro-Phe-Pro (FVAPFP), originally isolated from yeast (Saccharomyces cerevisiae) extracts and now produced synthetically for cosmetic use. It is distinguished from other cosmetic peptides (Argireline, Matrixyl, GHK-Cu, Decapeptide-12) by its proposed mechanism — rather than mimicking a neurotransmitter fragment (Argireline), a collagen propeptide (Matrixyl), or a tyrosinase inhibitor (Decapeptide-12), Hexapeptide-11 is framed as a proteostasis modulator: it upregulates the proteasome, autophagy machinery, molecular chaperones, and Nrf2-mediated antioxidant response in skin fibroblasts. This places it in a small category of cosmetic peptides with a cellular-housekeeping mechanism rather than a structural or enzymatic target. Clinical human efficacy data is limited; the strongest evidence is from in vitro and ex vivo fibroblast studies.

What Hexapeptide-11 Is Investigated For

Hexapeptide-11 is investigated as a topical cosmetic peptide with a distinctive mechanism — it activates the proteasome, autophagy machinery, molecular chaperones, and the Nrf2 antioxidant response in cultured skin fibroblasts. In normal human fibroblasts, it suppresses oxidative-stress-induced premature senescence and, in ex vivo skin deformation assays, improves elasticity. The mechanistic story is interesting because proteostasis decline is a recognized hallmark of aging, and most cosmetic peptides don't target this layer. The caveats are substantial: the published evidence comes primarily from one 2015 Gonos-group paper in Free Radical Biology and Medicine, independent clinical replication is limited, and human RCT data for topical Hexapeptide-11 on measurable skin outcomes (wrinkle depth, elasticity, pigmentation) is essentially absent. It's best understood as a mechanistically interesting cosmetic ingredient with a thin clinical evidence base rather than a validated anti-aging therapeutic.

How It Works

Hexapeptide-11 is a short peptide originally from yeast that appears to act like a "spring cleaning signal" for skin cells. It activates the cellular machinery that breaks down damaged proteins (proteasome and autophagy) and turns on the antioxidant defense system (Nrf2). In lab studies, this makes aged fibroblasts behave more like young ones. Whether that translates to visible skin improvement in humans hasn't been rigorously proven, but the mechanism is biologically interesting.

Hexapeptide-11 (FVAPFP) has been characterized primarily through in vitro studies in human diploid fibroblasts. Exposure to the peptide produces dose- and time-dependent upregulation of: (1) proteasomal subunit expression and peptidase activities, promoting degradation of damaged or oxidized proteins; (2) autophagy-lysosome system genes including BECN1, SQSTM1 (p62), and HDAC6, supporting turnover of protein aggregates and damaged organelles; (3) molecular chaperones HSF1, HSP27, HSP70, HSP90, and clusterin (CLU), which refold or escort damaged proteins; and (4) Nrf2 nuclear accumulation with downstream antioxidant response element (ARE) target gene activation. The net cellular effect is suppression of oxidative-stress-induced premature senescence and improved proteostasis capacity. The cellular receptor or primary target protein that mediates these broad transcriptional effects is not fully established — whether Hexapeptide-11 binds a specific surface receptor, translocates into cells, or acts indirectly via surface engagement is not definitively characterized. Ex vivo skin deformation assays suggest these cellular changes translate to improved biomechanical elasticity.

Evidence Snapshot

Forms & Administration

Topical application in serums, creams, and comprehensive anti-aging formulations. Typically included at low concentrations alongside other actives. Skin penetration is a general challenge for hexapeptides — formulation (liposomal carriers, microneedling-assisted delivery) affects dermal bioavailability. Not for injection. Best used as part of a broader evidence-based skincare regimen rather than a stand-alone anti-aging intervention.

Common Questions

Safety Profile